C12ORF57 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.63680180520487E-12 |
Normal-vs-Stage2 |
4.41130000000678E-05 |
Normal-vs-Stage3 |
3.50789952641151E-10 |
Normal-vs-Stage4 |
9.56940005014673E-09 |
Stage1-vs-Stage2 |
4.552800E-01 |
Stage1-vs-Stage3 |
8.813800E-01 |
Stage1-vs-Stage4 |
7.115600E-01 |
Stage2-vs-Stage3 |
4.307600E-01 |
Stage2-vs-Stage4 |
6.530200E-01 |
Stage3-vs-Stage4 |
6.695800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62458935193399E-12 |
Normal-vs-AfricanAmerican |
2.85379999998003E-06 |
Normal-vs-Asian |
2.939600E-01 |
Caucasian-vs-AfricanAmerican |
9.951600E-01 |
Caucasian-vs-Asian |
1.428380E-02 |
AfricanAmerican-vs-Asian |
2.235700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62458935193399E-12 |
Normal-vs-Female |
2.67480482207816E-11 |
Male-vs-Female |
2.358300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.735700E-03 |
Normal-vs-Age(41-60Yrs) |
1.75270908897573E-12 |
Normal-vs-Age(61-80Yrs) |
1.73627778821128E-12 |
Normal-vs-Age(81-100Yrs) |
1.441860E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.117600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.070200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.565800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.864400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.975400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.075800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.583510E-04 |
Normal-vs-Grade 2 |
1.62736490949555E-12 |
Normal-vs-Grade 3 |
2.4686919175565E-12 |
Normal-vs-Grade 4 |
1.86140000002499E-06 |
Grade 1-vs-Grade 2 |
2.838600E-01 |
Grade 1-vs-Grade 3 |
6.869000E-01 |
Grade 1-vs-Grade 4 |
8.946000E-01 |
Grade 2-vs-Grade 3 |
2.334000E-01 |
Grade 2-vs-Grade 4 |
2.637200E-01 |
Grade 3-vs-Grade 4 |
7.438600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62458935193399E-12 |
Normal-vs-ccB subtype |
7.04910000037806E-07 |
ccA subtype-vs-ccB subtype |
9.142300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.97892871165595E-12 |
Normal-vs-N1 |
7.495800E-02 |
N0-vs-N1 |
9.832200E-01 |
|
|